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ABSTRACT	42 
	43 
Background	44 
We	 explored	 the	 hypothesis	 that	 increased	 cholinergic	 tone	 exerts	 its	 pro‐arrhythmic	45 
effects	 in	 Brugada	 Syndrome	 (BrS)	 through	 increasing	 dispersion	 of	 transmural	46 
repolarisation	in	patients		with	spontaneous	and	drug	induced	Brugada	Syndrome.		47 
	48 
Methods	&	Results	49 
Electrophysiological	 studies	 in	 control	 patients	 with	 SVT	 only	 demonstrated	 shorter	50 
endocardial	 than	 epicardial	 right	 ventricular	 (RV)	 activation	 times	 (AT’s)	 (mean	51 
difference:	 26	ms,	 p<0.001).	 In	 contrast,	 BrS	 patients	 showed	 longer	 endocardial	 than	52 
epicardial	 AT	 (mean	 difference:	 ‐15	 ms,	 p=0.001).	 BrS	 hearts,	 compared	 to	 controls,	53 
showed	 significantly	 larger	 transmural	 gradients	 (TMG)	 in	 their	 activation	 recovery	54 
intervals	 (ARIs)	 (mean	 intervals	20.5	vs	3.5	ms;	p<0.01),	with	 longer	endocardial	 than	55 
epicardial	ARIs.	Edrophonium	challenge	increased	such	gradients	in	both	controls	(to	a	56 
mean	 of	 16	 msecs	 (p<0.001)	 and	 BrS	 (to	 29.7	 ms;	 p<0.001).	 However,	 these	 were	57 
attributable	 to	 epicardial	 and	 endocardial	ARI	 prolongations	 in	 control	 and	BrS	 hearts	58 
respectively.		Dynamic	changes	in	repolarisation	gradients	were	also	observed	across	the	59 
BrS	RV	wall	in	BrS.	60 
	61 
Conclusions:	62 
Differential	contributions	of	conduction	and	repolarisation	were	identified	in	BrS	which	63 
critically	modulated	transmural	dispersion	of	repolarisation	with	significant	cholinergic	64 
effects	only	identified	in	the	BrS	patients.	This	has	important	implications	for	explaining	65 
the	pro‐arrhythmic	effects	of	increased	vagal	tone	in	BrS	aswell	as	evaluating	autonomic	66 
modulation		&	epicardial	ablation	as	therapeutic	strategies.	67 
	68 
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	74 
INTRODUCTION	75 
	76 
Brugada	Syndrome	 (BrS)	 remains	one	of	 the	most	 important	 causes	of	 sudden	cardiac	77 
death	 in	 the	 young,	 accounting	 for	 20%	 of	 such	 cases1.	 Its	 molecular	 basis	 remains	78 
uncertain.	Ion	channel	mutations	primarily	involving	the	sodium	channel	have	only	been	79 
identified	 in	 up	 to	 30%	 of	 subjects2.	 The	 pathophysiological	 basis	 for	 its	 associated	80 
arrhythmias	 also	 remains	 contentious.	 BrS	 is	 characterised	 by	 a	 triad	 of	 right	 bundle	81 
branch	 block	 (RBBB),	 coved	 ST	 elevation	 in	 the	 right	 precordial	 leads	 and	 lethal	82 
ventricular	arrhythmias.	The	disease	appears	localised	to	the	right	ventricle	(RV)	where	83 
dynamic	 changes	 in	 ST	 elevation	 and	 ventricular	 arrhythmias	 develop	 in	 situations	 of	84 
increased	vagal	tone.		85 
	86 
High	 density	 intra‐cardiac	mapping	 by	 our	 group	 has	 identified	 significant	 conduction	87 
delays	in	the	RV	outflow	tract	(RVOT)	compared	to	the	RV	body	and	apex	in	BrS	relative	88 
to	findings	in	control	patients3.	These	data	have	been	corroborated	and	it	is	now	evident	89 
that	 BrS	 is	 further	 associated	 with	 marked	 epicardial	 conduction	 abnormalities	 and	90 
increased	fibrosis4‐7.	Such	fibrotic	changes	could	lead	to	electrotonic	uncoupling	between	91 
myocytes	 with	 source:sink	 mismatches	 between	 endocardium	 and	 epicardium.	 These	92 
could	 produce	 the	 alterations	 in	 conduction	 or	 repolarisation	 gradients	 reported	 in	 a	93 
recent	 mechanistic	 human	 study8.	 BrS	 has	 a	 more	 common	 nocturnal	 occurrence	 of	94 
ventricular	 fibrillation	 which	 occurs	 in	 parallel	 with	 a	 corresponding	 nocturnal	95 
accentuation	 of	 its	 pathognomonic	 ECG	 features9.	 These	 in	 turn	 correspond	 to	 the	96 
increased	vagal	and	diminished	sympathetic	activity	during	periods	of	rest10.	However,	97 
the	 electrophysiological	 effects	 of	 changes	 in	 autonomic	 tone	 on	 the	 BrS	 substrate	98 
remain	uncertain.			99 
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Here	 we	 explore	 the	 hypothesis	 that	 in	 BrS	 such	 increased	 cholinergic	 tone	 induces	100 
conduction	 delay	 and	 promotes	 either	 intramural	 or	 transmural	 dispersions	 of	101 
repolarisation	 in	the	RVOT.	We	evaluated	the	effect	of	cholinergic	activation	on	 in	vivo	102 
electrophysiological	 properties	 of	 the	 RV	 endocardium	 and	 RV	 epicardium	 in	 BrS	103 
patients.		104 
	105 
106 
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METHODS	107 
The data, analytic methods, and study materials will be made available to other researchers for 108 
purposes of reproducing the results or replicating the procedure on direct request.  109 
Human	electrophysiological	mapping	110 
The	non‐contact	mapping	study	and	pacing	protocol	were	performed	prior	to	ablation	in	111 
the	control	patients	or	VT	stimulation	studies	in	the	Brugada	Syndrome	(BrS)	group.	All	112 
anti‐arrhythmic	 drugs	 had	 first	 been	 stopped	 for	 at	 least	 5	 half	 lives	 prior	 to	 the	113 
procedures.	 The	 detailed	 techniques	 for	 non‐contact	 mapping	 in	 the	 ventricle	 are	114 
described	 elsewhere12.	 The	 multi‐electrode	 array	 (MEA)	 (Ensite,	 St	 Jude	 Medical,	 St. 115 
Paul, Minnesota, USA)	was	deployed	via	 the	 left	 femoral	 vein	 in	 the	 right	ventricular	116 
outflow	 tract	 (RVOT)	 (full	 methodology	 described	 previously3).	 An	 epicardial	 16‐pole	117 
Pathfinder	catheter	 (Cardima,	California,	USA)	was	passed	 into	 the	distal	great	 cardiac	118 
vein	in	the	interventricular	groove	(Fig.	 	1).	All	patients	gave	informed	consent	and	the	119 
study	was	approved	by	the	University	College	London	Hospital	(UCLH)	Research	Ethics	120 
Committee.	121 
	122 
Programmed	 ventricular	 stimulation	 was	 performed	 from	 the	 right	 ventricular	 apex.	123 
Three	minutes	of	steady	state	pacing	at	a	coupling	interval	of	400	ms	was	followed	by	a	124 
S1S2	 restitution	 protocol	 using	 400	 ms	 drive	 trains.	 The	 extrastimulus	 was	 initially	125 
extended	 progressively	 by	 50	 ms	 intervals	 until	 consistent	 fusion	 with	 sinus	 beats	126 
occurred.	The	S1S2	interval	was	thereafter	decreased	at	20	ms	intervals	to	300	ms,	then	127 
by	 5	 ms	 until	 the	 ventricular	 effective	 refractory	 period	 (VERP)	 was	 reached.	 The	128 
protocol	was	repeated	following	intravenous	(IV)	administration	of	10	mg	edrophonium	129 
to	increase	cholinergic	tone,	then	followed	by	a	10	min	washout	period.	130 
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Offline	analysis	131 
24	virtual	unipolar	electrograms	were	placed	in	the	RVOT	in	4	columns	of	6	virtuals	to	132 
obtain	 local	endocardial	data	within	3	cm	of	 the	array	directly	opposite	the	position	of	133 
the	 16	 pole	 Cardima	 catheter	 (Fig.	 1).	 Endocardial	 &	 epicardial	 electrograms	 were	134 
exported	and	analysed	using	semi‐automated	custom	software	 running	 in	Matlab	 (The	135 
Mathworks	 Inc.,	 MA,	 USA)	 (Figure	 S1).	 All	 electrograms	 and	 analyses	 were	 manually	136 
checked	 by	 3	 independent	 observers	 (JBA,	 MF,	 DS).	 The	 time	 from	 the	 earliest	137 
electrogram	recorded	within	the	right	ventricle	(RV)	to	the	steepest	negative	deflection	138 
((dV/dt)min)	was	used	as	the	local	activation	time	(AT).	The	sinus	rhythm	AT	of	 the	RV	139 
was	taken	as	the	time	from	earliest	to	latest	recorded	RV	activation.	During	pacing,	the	140 
time	from	the	pacing	artefact	to	the	time	corresponding	to	the	(dV/dt)min	was	used	as	the	141 
local	 AT.	 Two	 methods	 have	 been	 used	 to	 measure	 repolarisation	 times	 during	 non‐142 
contact	mapping,	 respectively	 termed	 the	classical	 (Wyatt)	method	and	 the	alternative	143 
method.	Both	have	come	under	 intense	theoretical	and	experimental	scrutiny;	here	we	144 
present	results	using	the	classical	method13‐16.	Activation	repolarisation	interval	(ARI),	a	145 
well‐validated	 approximation	 of	 action	 potential	 duration,	 was	 defined	 as	 the	 interval	146 
between	 the	 AT	 and	 repolarization	 time	 (Figure	 S1).	 The	 slope	 of	 ARI	 restitution	was	147 
calculated	 using	 the	 least	 mean	 squares	 method17,18.	 The	 RVOT	 was	 divided	 into	 4	148 
anatomical	regions	(anterior,	posterior,	lateral	septal),	and	activation	and	repolarisation	149 
dynamics	were	studied	in	the	RVOT	endocardium	and	epicardium.	150 
Endocardial	&	Epicardial	Regional	Delay	151 
Mean	increase	of	delay	(MID)	was	calculated	by	dividing	the	integrated	increase	of	delay	152 
(area	under	the	curve)	by	the	interval	between	baseline	cycle	length	and	the	refractory	153 
period.19	The	 degree	 of	 delay	was	measured	 from	4	 segments	 in	 the	RVOT	 and	 in	 the	154 
epicardium.		155 
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Genetic	testing	156 
Blood	samples	(10	mL)	were	obtained	from	participating	BS	subjects.	Genomic	DNA	was	157 
isolated	 from	 peripheral	 blood	 leukocytes	 with	 the	 use	 of	 a	 commercial	 kit	 (Gentra	158 
System,	 Puregene).	 The	 exons	 of	 SCN5A	 were	 amplified	 and	 analyzed	 by	 direct	159 
sequencing.	 Polymerase	 chain	 reaction	products	were	purified	with	Exosap	 (USB)	 and	160 
were	directly	 sequenced	 from	both	 directions	with	 the	ABI	 PRISM	BigDye	Terminator	161 
Cycle	Sequencing	Reaction	and	the	ABI	PRISM	3130XL	Automatic	DNA	Sequencer.	162 
	163 
Statistical	analysis	164 
All	statistical	computing	was	performed	using	R	software	(The Comprehensive R Archive 165 
Network (CRAN)). Continuous	 parametric	 data	 are	 presented	 as	 means	 ±	 standard	166 
deviations	(SD)	or,	in	the	case	of	significance	derived	from	regression	models,	mean	with	167 
[95%	 confidence	 interval],	 unless	 otherwise	 specified.	 Comparisons	 in	 which	 a	 single	168 
measurement	 was	 taken	 for	 each	 subject,	 e.g.	 ventricular	 effective	 refractory	 period	169 
(VERP),	 dispersion	 of	 repolarisation	 time,	were	made	using	 Student’s	 t‐test	with	 post‐170 
hoc	 correction	 for	 multiple	 comparisons.	 Continuous	 parametric	 data	 derived	 from	171 
electrogram	data	were	modelled	using	mixed‐effects	 linear	 regression (software: Linear 172 
and Nonlinear Mixed Effects (NLME) package running in R version 2.14)	 and	 statistical	173 
significance was inferred from the model. Quartile regression with bootstrapping (Quantile 174 
Regression Description Estimation and inference (QUANTREG)	 package)	 was	 used	 to	175 
compare	non‐parametric	continuous	data.	176 
	177 
RESULTS	178 
Mapping	was	performed	in	16	patients	(BrS	group:	n	=	8,	5M:	2F;	mean	age	56	y	,		control	179 
group:	n=8,	5M:	3F;	mean	age	48,).	The	demographic	data	is	shown	in	Table	1.	Four	BrS	180 
patients	had	resting	type	1	ECGs	and	two	had	a	family	history	of	sudden	cardiac	death.	181 
No	significant	structural	abnormalities	were	detected	on	echocardiography	or	MRI	with	182 
MRI	excluding	gadolinium	 late	 enhancement	or	T1	mapping	 abnormalities	 in	 the	 right	183 
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and	 left	 ventricles	 in	 the	 4	 scanned	 cased.	 Only	 one	 patient	 had	 an	 ICD	 inserted	 for	184 
symptomatic	non‐sustained	VT	and	none	have	had	any	significant	ventricular	arrhythmic	185 
events	in	8	years	of	follow‐up.		186 
	187 
Genetic	 data	 are	 available	 in	 4	 subjects:	 BrS	 cases	 3‐5	 were	 negative	 for	 known	188 
pathogenic	 SCN5A	mutations	 and	 BrS	 subject	 8	was	 a	 carrier	 of	 a	 c.3045_3046delGA,	189 
exon	17	SCN5A	,which	is	predicted	to	cause	a	frameshift	of	the	amino	acid	sequence	in	190 
leading	to	a	premature	termination	of	translation.	191 
	192 
The	 control	 group	 of	 patients	 had	 SVT.	 They	 had	 normal	 resting	 and	 signal	 averaged	193 
ECGs,	a	negative	ajmaline	challenge	test,	structurally	normal	hearts	on	echocardiography	194 
and	no	family	history	of	sudden	cardiac	death.	Informed	consent	was	obtained	following	195 
local	 research	 ethics	 committee	 approval.	 We	 used	 the	 acetylcholinesterase	 inhibitor	196 
edrophonium	to	activate	muscarinic	receptors.		197 
	198 
We	made	direct	measurements	of	epicardial	and	endocardial	activation	times	(AT),	and	199 
activation	recovery	intervals	(ARI),	from	which	we	further	derived	recovery	times	(RTs)	200 
in	both	control	and	BrS	patients	before	and	following	autonomic	edrophonium	challenge.	201 
This	permitted	us	to	derive	the	transmural	gradients	in	AT,	ARI	and	RTs,	relating	these	202 
phenotypic	characteristics	to	findings	in	BrS	or	normal	patients.	203 
During	 steady	 pacing,	 epicardial	 activation	 times	 (ATs)	 and	 activation	 recovery	204 
intervals	 (ARIs)	were	 significantly	 shorter	 in	BrS	 than	 in	 control	 patients	 and	neither	205 
were	significantly	affected	by	edrophonium	challenge	(Fig.	S2).		In	contrast,	endocardial	206 
AT	 and	 ARI	 were	 significantly	 longer	 in	 BrS	 than	 control	 patients,	 and	 similarly	 only	207 
minimally	affected	by	edrophonium	challenge.		208 
Formatted: Font color: Red
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Measurements	made	through	varying	coupling	intervals	used	to	construct	restitution	209 
curves	demonstrated	 that	 control	patients	 showed	shorter	endocardial	 than	epicardial	210 
ATs	 that	 gave	 mean	 AT	 differences	 of	 26	 ms,	 95%	 CI:	 21,	 32	 for	 endocardium	 and	211 
epicardium	 respectively,	 p<0.001(Fig.	 2).	 In	 contrast,	 the	 BrS	 patients	 showed	 longer	212 
endocardial	 AT	 than	 epicardial	 AT	 (mean	 AT	 difference:	 15	 ms,	 95%	 CI	 11,	 20,	 for	213 
endocardium	and	epicardium	respectively;	p=0.001).	Following	edrophonium	challenge,	214 
both	 endocardial	 and	 epicardial	 ATs	 were	 unchanged	 in	 the	 control	 but	 significantly	215 
further	shortened	in	the	BrS	patients.	However,	neither	control	nor	BrS	patients	showed	216 
significant	changes	in	their	transmural	activation	time	differences.	When we measured the 217 
regional delay to assess conduction reserve, this was greater in the epicardium than 218 
endocardium in BrS versus controls and was further exaggerated following edrophonium (Fig 219 
S3).  220 
	221 
Hearts	 from	 the	control	patients	 showed	minimal	 transmural	gradients	 (TMG)	 in	 their	222 
ARIs	 (mean	 3.4	 ms,	 95%	 CI:	 6.8,	 0.02,	 p<0.05)	 with	 endocardial	 ARIs	 that	 were	223 
marginally	shorter	than	epicardial	ARIs	(Fig.	3).	In	contrast,	hearts	from	the	BrS	patients	224 
showed	 significantly	 larger	 TMG	 (mean	 20.5	 ms,	 95%	 CI:	 25.5,	 15.5,	 p<0.001),	 with	225 
shorter	epicardial	ARIs	than	endocardial	ARIs.	226 
Following	edrophonium	challenge,	the	TMG	in	hearts	from	control	patients	increased	to	227 
a	 mean	 of	 16	 ms	 (95%	 CI:	 19.6,	 12.6,	 p<0.001),	 and	 this	 reflected	 an	 epicardial	 ARI	228 
prolongation.	The	TMG	in	hearts	from	BrS	patients	increased	to	29.7	ms	(95%	CI:	35.3,	229 
24.1,	p<0.001),	but	this	reflected	endocardial	as	opposed	to	epicardial	ARI	prolongation.	230 
These	 effects	 were	 particularly	 evident	 from	 contact	 endocardial	 and	 epicardial	231 
electrogram	 recordings	 illustrating	 the	 unipolar	 electrogram	 morphologies	 in	 hearts	232 
from	 BrS	 versus	 control	 patients	 and	 the	 effects	 of	 edrophonium	 on	 the	 degree	 of	 ST	233 
elevation	in	the	epicardium	(Fig.	4).	234 
	235 
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In	control	patients,	epicardial	repolarisation	as	reflected	in	its	repolarisation	times	(RT)	236 
was	completed	later	than	endocardial	repolarisation.	The	resulting	RT	gradient	therefore	237 
ran	 from	 epi‐	 to	 endocardium.	 However,	 in	 the	 BrS	 patients,	 epicardial	 repolarisation	238 
was	 completed	 earlier	 than	 endocardial	 repolarisation	 and	 showed	 smaller	 values	 at	239 
long	 cycle	 lengths.	 This	 resulted	 in	 a	 reversed	 RT	 gradient	 with	 significantly	 shorter	240 
epicardial	versus	endocardial	RTs.	Edrophonium	challenge	left	the	RT	gradient	flat	and	241 
unaffected	across	all	the	coupling	intervals	in	the	control	patients.	In	contrast,	in	the	BrS	242 
patients,	edrophonium	challenge	resulted	in	a	significant	increase	in	the	epicardial	RTs	243 
which	 was	 most	 pronounced	 at	 longer	 CI’s.	 The	 RT	 gradients	 across	 the	 coupling	244 
intervals	altered	particularly	at	shorter	intervals	(Fig.	5).	245 
	246 
Maximum	restitution	slopes	247 
Epicardial	maximum	restitution	slopes	(Smax)	at	baseline	were	steeper	(p<0.05)	in	hearts	248 
of	 patients	with	 BrS	 (mean	 0.887,	 SEM	 0.065)	 compared	with	 control	 patients	 (mean	249 
0.728,	 SEM	 0.046)	 with	 no	 significant	 changes	 following	 edrophonium	 challenge.	 The	250 
values	of	 Smax	 in	 the	 anterior	RVOT	endocardium	were	 similar	 in	hearts	 from	BrS	 and	251 
control	patients,	and	showed	no	significant	changes	following	edrophonium	challenge.	In	252 
contrast,	 edrophonium	 decreased	 the	 whole	 RVOT	 endocardial	 Smax	 in	 hearts	 from	253 
control	patients	 (from	mean	0.68,	SEM	0.031	to	mean	0.544,	SEM	0.023,	p<0.001),	but	254 
produced	no	significant	corresponding	changes	in	hearts	from	the	BrS	patients.	255 
	256 
	257 
Discussion		258 
We	report	the	first	detailed	in	vivo	investigation	of	the	effects	of	autonomic	modulation	259 
on	right	ventricular	 endocardial	and	epicardial	 electrophysiology	 in	BrS.	This	 revealed	260 
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that	the	modulation	of	activation	and	repolarisation	gradients	by	premature	stimuli	may	261 
be	greater	in		BrS.		262 
	263 
Our	 studies	 determined	 epicardial	 and	 endocardial	 activation	 times	 (AT),	 activation	264 
recovery	 intervals	 (ARI),	 and	 recovery	 times	 (RTs)	 in	 both	 control	 and	 BrS	 patients.	265 
From	 these	 we	 derived	 the	 corresponding	 transmural	 gradients	 in	 AT,	 ARI	 and	 RTs	266 
before	 and	 following	 autonomic	 edrophonium	 challenge	 and	 related	 these	 phenotypic	267 
characteristics	 to	 findings	 in	BrS	or	normal	patients.	We	observed	significant	effects	of	268 
both	 absolute	 and	 transmural	 differences	 between	 both	 conduction	 and	 repolarisation	269 
characteristics	 and	 differing	 effects	 upon	 these	 of	 cholinergic	 challenge.	 We	 thus	270 
associated	differences	in	the	spatial	organisation	and	heterogeneity	of	these	changes	in	271 
activation	and	repolarisation	with	the	BrS	condition.	272 
Our	key	findings	concerned	abnormalities	in	the	transmural	gradients	of	both	activation	273 
and	repolarisation	in	Brugada	syndrome	patients	and	their	accentuation	by	cholinergic	274 
stimulation.	 Thus,	 whereas	 in	 control	 individuals,	 the	 epicardium	 completed	275 
repolarisation	before	the	endocardium,	in	BrS	this	sequence	was	reversed.	Edrophonium	276 
modulated	the	abnormal	transmural	gradient	in	BrS	leading	to	further	delayed	epicardial	277 
repolarisation.			This	reflected	differential	effects	of	the	BrS	condition	and	of	cholinergic	278 
challenge	 upon	 conduction	 velocity	 and	 repolarisation	 which	 govern	 the	 transmural	279 
activation	sequence.	Thus,	prior	to	cholinergic	challenge,	 the	main	differences	between	280 
human	BrS	 and	 controls	 reflected	 epicardial	 differences	with	 the	BrS	 showing	 shorter	281 
ARI’s	 and	 the	 epicardium	 activating	 earlier	 than	 the	 endocardium.	 This	 parallels	 the	282 
findings	of	other	groups7,8,	20.	Indeed	the	largest	mean	ARI	gradient	at	rest	is	equivalent:	283 
20.5ms	 versus	 24ms	 in	 the	 Langendorrff	 study	 of	 a	 Brugada	 heart20.	 	 This	 causes	 a	284 
significant	 reversed	 repolarisation	 gradient	 to	 arise	 from	 endocardium	 to	 epicardium	285 
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which	 did	 not	 exist	 in	 controls.	 	 Increased	 cholinergic	 tone	 through	 edrophonium	286 
administration	 exerted	 additional	 important	 effects	 on	 conduction‐repolarisation	287 
dynamics	in	BrS	with	significant	differences	in	epi	and	endocardial	electrophysiological	288 
responses.		There	is	a	reversed	ARI	gradient	in	BrS	patients	with	shorter	epicardial	ARI’s	289 
compared	with	a	smaller	opposite	ARI	gradient	in	normal	individuals	at	baseline.	These	290 
differences	are	exacerbated	by	increased	cholinergic	tone	with	preferential	endocardial	291 
ARI	prolongation	in	BrS.		292 
	293 
The	 findings	 may	 reflect	 a	 differential	 distribution	 of	 ion	 channels	 between	 the	294 
endocardium	 and	 epicardium21.	 Differences	 in	 sodium	 channel,	 calcium	 channel	 and	295 
potassium	 channel	 expression	 and	 differential	 regulation	 of	 currents	 by	 autonomic	296 
pathways	 are	 likely	 to	 account	 for	 the	 striking	 endo	 and	 epicardial	 differences.	 This	297 
indicates	a	 loss	of	endocardial	 	 to	epicardial	conduction	reserve	which	could	be	due	to	298 
abnormalities	 in	 the	Purkinje	network	preventing	rapid	endocardial	 tissue	recruitment	299 
and	 subsequent	 endo–epicardial	 depolarisation	 as	 well	 as	 reduced	 tissue	 coupling	300 
secondary	to	lack	of	Na	channel	recruitment	(excitability)	and	tissue	fibrosis.		301 
	302 
The	data	also	show	that	increased	cholinergic	tone	promotes	heterogeneity	between	epi	303 
and	 endocardium	 and	 suggests	 the	main	 cholinergic	 effects	 in	 BrS	 are	 exerted	 on	 the	304 
endocardial	ARI,	combined	with	conduction	delays	amplifying	transmural	repolarisation	305 
dynamic	differences	across	coupling	intervals.	The	marked	conduction	delays	especially	at	306 
short	 coupling	 intervals	 in	 these	 studies	 in	 conjunction	 with	 the	 shorter	 ARI’s	 in	 the	307 
Brugada	 heart	 create	 the	 optimal	 conditions	 to	 promote	 large	 endo‐epicardial	308 
conduction	and	repolarisation	gradients.		309 
	310 
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The	electrophysiological	changes	reported	here	may	also	bear	upon	the	“conduction	and	311 
repolarisation	hypotheses”	explaining	the	characteristic	clinical	ECG	waveform	in	BrS22.		312 
These	 variously	 explain	 its	 coved	 ST	 elevation	 by	 delayed	 depolarisation	 from	 the	 RV	313 
body	 to	RVOT	or	 transmural	gradients	 in	repolarisation	secondary	 to	a	shortened	“dip	314 
and	 plateau”	 action	 potential	morphology	 in	 the	 epicardium.	 The	 present	 findings	 are	315 
consistent	with	a	combination	of	these	mechanisms.	This	would	be	compatible	with	the	316 
differential	conduction	delay	between	the	endocardium	and	epicardium	and	the	earlier	317 
epicardial	 repolarisation	 in	 BrS.	 Furthermore,	 changes	 in	 coupling	 interval	 modulate	318 
these	 features	 on	 a	 beat	 to	 beat	 basis,	 and	 this	 would	 promote	 the	 creation	 of	319 
endocardial‐epicardial	 repolarisation	 gradients	 and	 hence	 ST	 elevation	 in	 the	 right	320 
precordial	 leads	 with	 the	 gradients	 particularly	 in	 the	 presence	 of	 electrotonic	321 
uncoupling	promoted	by	structural	abnormalities23,24.		322 
	323 
The	 findings	 also	 have	 implications	 for	 electrocardiographic	 changes	 following	324 
conditions	of	increased	cholinergic	tone	in	BrS.	 	Thus,	increased	vagal	tone	is	known	to	325 
produce	dynamic	changes	in	J	point	elevation	and	ventricular	arrhythmia.	Nakazawa	et	326 
al.	 reported	 that	 high	 vagal	 tone	 and	 low	 sympathetic	 tone	 are	 specific	 properties	 of	327 
symptomatic	BrS	on	the	basis	of	heart	rate	variability	data	25.	Their	study	also	suggested	328 
these	 autonomic	 imbalances	were	 significant	 in	 the	 symptomatic	 group	but	 not	 in	 the	329 
asymptomatic	group.	Dynamic	changes	in	J	point	elevation	are	more	prominent	at	night	330 
particularly	 in	patients	with	previous	VF.	Abnormal	123I‐MIBG	uptake	 in	patients	with	331 
BrS	is	described	indicating	presynaptic	sympathetic	dysfunction	of	the	heart	shifting	the	332 
influence	to	increases	in	cholinergic	tone26.	The	precise	relationship	between	vagal	tone	333 
and	pro‐arrhythmia	is	subject	to	debate.	Increased	vagal	tone	is	thought	to	reduce	the	Ca	334 
transient	 during	 phase	 2	 of	 the	 action	 potential	 resulting	 in	 increased	 transmural	335 
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dispersion	of	repolarisation	and	phase	2	re‐entry27.	The	data	supporting	this	hypothesis	336 
has	 been	 derived	 from	 the	 canine	 RV	 wedge	 preparation	 of	 BrS	 employing	337 
pharmacological	manipulations	to	reproduce	the	Brugada	ECG.		338 
This	 study	 demonstrates	 that	 autonomic	 effects	 are	 2‐fold‐promoting	 endocardial	 ARI	339 
prolongation	with	marked	shortening	of	endo	and	epicardial	AT.	These	2	effects	will	be	340 
highly	pro‐arrhythmic	enabling	endocardial	functional	conduction	block	and	promoting	341 
a	large	vulnerable	window	epicardially	to	facilitate	re‐entry.		342 
Limitations	343 
We	were	unable	to	biopsy	the	sites	of	recording	or	undertake	direct	epicardial	recording	344 
of	 the	 substrate	 	 so	 it	 is	 possible	 that	more	 severely	 diseased	 areas	were	not	 studied.	345 
Nevertheless,	 these	 findings	 indicate	 sufficient	 pathology	 was	 present	 to	 enable	346 
significant	 differences	 in	 conduction‐repolarisation	 dynamics	 to	 be	 identified.	 These	347 
findings	 provide	 evidence	 of	 conduction‐repolarisation	 abnormalities	 in	 BrS	 without	348 
events	 but	 the	 extent	 of	 such	 changes	 need	 to	 be	 explored	 in	more	 severely	 affected	349 
individuals	as	 there	 is	preliminary	evidence	 to	suggest	 that	such	cases	may	have	more	350 
marked	 conduction	 abnormalities	 using	 ECG	 Imaging28,29	 .	 Indeed	 the	 extent	 of	 these	351 
changes	could	be	used	as	a	risk	marker	for	lethal	arrhythmias.	352 
	353 
These	 data	 have	 important	 clinical	 implications	 with	 recent	 interest	 in	 epicardial	354 
substrate	 ablation	 to	 prevent	 VF	 in	BrS30,31.	 Ablation	 appears	 to	 normalise	 the	 resting	355 
ECG	and	prevent	dynamic	ST	elevation.	This	may	operate	by	homogenising	the	substrate	356 
such	 that	 endo	and	epicardial	gradients	 can	no	 longer	be	generated	 in	 the	RVOT.	This	357 
will	prevent	changes	in	cholinergic	tone	influencing	the	gradient	&	enabling	VF	initiation	358 
if	 these	 transmural	 gradients	 are	 primarily	 responsible	 for	 arrhythmogenesis.  . 359 
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		Figure	Legends	
	
Figure	1.	Positioning	of	Mapping	Catheters	in	the	RV	and	great	cardiac	vein	to	record	RV	
endocardial	and	epicardial	electrograms.	
	
	
Figure	2	.	 	Endo	and	Epicardial	Activation	time	dynamics	pre	and	post	edrophonium	in	
control	and	Brugada	hearts.	
	
Figure	3.	Endo	and	Epicardial	ARI	dynamics	pre	and	post	edrophonium	in	control	and	
Brugada	Hearts.	
	
Figure	 4.	 Example	 of	 Sinus	 rhythm	 ECG	 and	 Electrograms	 Recorded	 epi	 and	
endocardially	in	a	Control	and	BrS	patient.	There	is	a	type	II	coved	ST	elevation	pattern	
resting	ECG	of	the	BrS	patient	which	Is	reflected	in	the	epicardial	unipolar		electrograms‐
these	are	exaggerated	after	edrophonium	(blue)	aswell	as	a	decrease	in	activation	times	
 20
in	 the	 epicardial	 electrograms	 .	 No	 significant	 change	 occurs	 in	 the	 control	 after	 the	
edrophonium.	
	
Figure	5.	Endo	and	Epicardial	Repolarisation	Time	dynamics	pre	and	post	edrophonium	
in	control	and	Brugada	Hearts.  
 
 
 
Supplemental	 Figure	 S1	 .	 Example	 of	 semi‐automated	 AT,	 ARI	 and	 RT	
measurements	from	intracardiac	Non‐contact	unipolar	signals.	The	blue	interrupted	
line	 is	 the	 dV/dt	 of	 the	 solid	 black	 line	 (which	 is	 the	 signal	 exported	 from	 Ensite	 NC	
mapping	system).	The	red	coloured	squares	mark	activation	times	(dV/dt	min)	and	the	
blue	dV/dt	max	of	the	T	wave	upstroke	to	measure	ARI:	the	Wyatt	method		was	used	to	
look	at	all	T	waves	employing	upstroke	of	the	T	wave.	
	
Supplemental	Figure	S2.	A.	Baseline	Epicardial	 	 AT,	ARI	 and	RT	 in	 Controls	 and	BrS	
during	 steady	 state	 pacing	 at	 400ms.	 *P<0.05	 between	 control	 and	 BrS.	 B.	 Baseline	
Endocardial	AT,	ARI	 and	RT	 in	 Controls	 and	BrS	during	 steady	 state	pacing	 at	 400ms.	
*P<0.05	between	control	and	BrS.	
	
Supplemental	Figure	S3	
Boxplots	 representing	 the	 mean	 increase	 delay	 (MID),	 endocardially	 (Endo)	 and	 epicardially	
(Epi),	 for	 both	 Control	 and	 Brugada	 subjects,	 before	 (Base)	 and	 after	 Edrophonium	 (Edr)	
administration.	 For	 the	 control	 group,	 a	 significant	 difference	 in	 the	MID	between	endocardial	
and	epicardial	regions	was	induced	by	drug	administration.	For	the	Brugada	group,	a	significant	
difference	was	already	present	at	baseline	and	was	further	exacerbated.	These	difference	were	
mainly	due	to	a	MID	prolongation	in	the	epicardium.	*P<0.05	**P<0.01	***P<0.001	
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